Stay updated with breaking news from Aurena. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Lipidor Announces Enrolment of First Patients in a Phase III Study on AKP02 for Treatment of PsoriasisSTOCKHOLM, Sweden, 26th January 2022 – Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today reports that the first patients have been enrolled in a Phase III clinical study using AKP02 cutaneous sp. ....
STOCKHOLM, Jan. 26, 2022 /PRNewswire/ Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) today reports that the first patients have been enrolled in a Phase III clinical study using ....
Lipidor : announces approval to start Phase III clinical study of drug candidate AKP02 for treatment of psoriasis marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Lipidor announces approval to start Phase III clinical study of drug candidate AKP02 for treatment of psoriasis prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.